Lupus Canada

Lupus Foundation of America and Lupus Canada Award Grant for Study Examining New Method to Predict Treatment Response in Lupus Nephritis to Improve Kidney Outcomes

Retrieved on: 
Monday, August 28, 2023
Lupus Foundation of America, Partnership, Lupus Canada, Doctor of Philosophy, Dialysis, Transplant, MD, Patient, Kidney, RN, Interferon, FRCPC, Gene, Pharmaceutical industry, Medical device, Nursing, Research, Lupus nephritis

Dr. Wither will be examining an inflammatory marker called IFN-induced genes in patients with lupus nephritis (lupus-related kidney disease).

Key Points: 
  • Dr. Wither will be examining an inflammatory marker called IFN-induced genes in patients with lupus nephritis (lupus-related kidney disease).
  • "The Lupus Canada Catalyst Award from the Lupus Foundation of America and Lupus Canada is allowing us to take critical steps in this research, which has the potential to improve kidney outcomes in patients with lupus nephritis."
  • "Dr. Wither's research on IFN-induced genes in patients with lupus nephritis holds the promise to revolutionize evaluation of lupus kidney biopsies and treatment strategies to improve kidney outcomes."
  • "Today's announcement between Lupus Canada and Lupus Foundation of America will kick start critical research into lupus nephritis clinical testing, with hope to improve treatment outcomes," said Thomas J. Simpson, Chair of Lupus Canada.

Lupus Foundation of America and Lupus Canada Award Grant for Critical Study Examining Platelet Biology as a Potential Lupus Treatment Pathway

Retrieved on: 
Wednesday, August 31, 2022
Center, Inflammation, Partnership, Lupus Canada, Lupus, CEO, Lupus Foundation of America, Research, Immunity, CHU, SLE, Doctor of Philosophy, B cell, Canada, Department, Quality of life, Education, Cell, Megakaryocyte, Immunology, Classification, Immune system, Thrombosis, Medicine, Medical device, Pharmaceutical industry, Microbiology

The findings from his study could uncover new pathways that impact lupus classification criteria and treatment.

Key Points: 
  • The findings from his study could uncover new pathways that impact lupus classification criteria and treatment.
  • "The Lupus Canada Catalyst Award from the Lupus Foundation of America and Lupus Canada is providing a unique opportunity to study this important area and utilize emerging new technologies to analyze these cells that hold potential promise for new lupus treatment pathways."
  • "Through our partnership with Lupus Canada we have been able to support even more researchers studying important new frontiers in lupus research," said Stevan W. Gibson, president and CEO, Lupus Foundation of America.
  • "The Lupus Canada Catalyst Grant, in partnership with the Lupus Foundation of America, illustrates our commitment to investing in Canadian researchers who are focused in the area of discoid or systematic lupus erythematosus (SLE).

Lupus Foundation of America and Lupus Canada Award Grant for Study Examining Cognitive Dysfunction in People with Lupus

Retrieved on: 
Thursday, August 19, 2021
University, Associate, Quality of life, Lupus Canada, University Health Network, Lupus, Lupus Foundation of America, College, Research, Disease, Doctor of Philosophy, Fatigue, Patient, Partnership, Magnetic resonance, CEO, Education, Hospital, Brain, Cognitive disorder, Lists of diseases, MD, Medicine, Pharmaceutical industry

Touma and Barraclough will be researching the causes of cognitive dysfunction in patients with lupus.

Key Points: 
  • Touma and Barraclough will be researching the causes of cognitive dysfunction in patients with lupus.
  • Cognitive dysfunction can affect up to 75% of people with lupus, which often manifests in the form of cognitive fatigue, or "brain fog."
  • This will show if the brains of people with lupus must work harder during cognitive tasks and could explain feelings of "brain fog" due to cognitive dysfunction.
  • "Working together with the Lupus Foundation of America through the Lupus Canada Catalyst Grant program we are ensuring research that can greatly impact people living with lupus has the support it needs while we invest in the brightest lupus researchers in North America," shared Malcolm Gilroy, Volunteer President, Lupus Canada.

Lupus Foundation of America Provides Six Grants to Young Scientists Supporting Important Lupus Research

Retrieved on: 
Thursday, July 22, 2021
Medical specialties, Medicine, Clinical medicine, Cutaneous lupus erythematosus, Lupus, William Osler, Lupus Canada

The fellowship program provides grant and mentorship support for young scientists and plays an important role in establishing the next generation of lupus researchers and the future of the lupus research field.

Key Points: 
  • The fellowship program provides grant and mentorship support for young scientists and plays an important role in establishing the next generation of lupus researchers and the future of the lupus research field.
  • Each 2021 Finzi awardee is mentored throughout their research project by an experienced lupus investigator, a critical component ensuring that the young scientists receive support and guidance as they establish themselves in lupus research.
  • The Gina M. Finzi Memorial Student Summer Fellowship Program has supported the work of nearly 200 young scientists in North America.
  • Past recipients from the program have gone on to lead innovative and groundbreaking lupus research and have become distinguished lupus scientists in the field.

SLE-UPDATE Study Finds Reducing Pain, Fatigue, and Flares are Top Treatment Goals for People with Lupus

Retrieved on: 
Monday, June 28, 2021
Medical specialties, Autoimmune diseases, Clinical medicine, Cutaneous lupus erythematosus, Medicine, Lupus, William Osler, Anti-SSA/Ro autoantibodies, Neonatal lupus erythematosus, Lupus Canada

The study, "Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey," was conducted by the Lupus Foundation of America and Eli Lilly and Company, and highlights the importance of patient reported symptoms and treatment goals to improve quality of life.

Key Points: 
  • The study, "Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey," was conducted by the Lupus Foundation of America and Eli Lilly and Company, and highlights the importance of patient reported symptoms and treatment goals to improve quality of life.
  • The SLE-UPDATE study is a follow-up study to the Lupus Foundation of America and Eli Lilly and Company UNVEIL survey from 2014 which examined the burden of SLE for patients and caregivers in the US.
  • "The voice of people with lupus is incredibly important when understanding treatment needs.
  • Read the full study here and check out an infographic highlighting findings from the study.

The Lupus Release Alliance Awards 2021 Lupus Insight Prize to Immunologist Dr. Martin Kriegel

Retrieved on: 
Wednesday, June 9, 2021
Medical specialties, Medicine, Clinical medicine, Cutaneous lupus erythematosus, Lupus, William Osler, Autoimmunity, Lupus Canada, The Hibbs Lupus Trust

The prestigious Lupus Insight Prize recognizes outstanding researchers who have made a major discovery that promises to advance the understanding of lupus with a high likelihood of improving its diagnosis or treatment.

Key Points: 
  • The prestigious Lupus Insight Prize recognizes outstanding researchers who have made a major discovery that promises to advance the understanding of lupus with a high likelihood of improving its diagnosis or treatment.
  • Although existing research links alterations in the microbiome to autoimmunity, Dr. Kriegel is the first to identify a particular organism that breaks through the gut lining in lupus.
  • The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide.
  • Because the Lupus Research Alliance's Board of Directors fund all administrative and fundraising costs, 100% of all donations goes to support lupus research programs.

Global Systemic Lupus Erythematosus Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Health, Other Health, Autoimmune diseases, Medical specialties, Clinical medicine, Connective tissue diseases, Medicine, Cutaneous lupus erythematosus, Lupus erythematosus, Lupus, Sjögren syndrome, Systemic, Acute cutaneous lupus erythematosus, Lupus Canada

b'The "Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Systemic Lupus Erythematosus Epidemiology and Patient Flow Analysis - 2021, provides Systemic Lupus Erythematosus epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Systemic Lupus Erythematosus Epidemiology and Patient Flow Analysis - 2021, provides Systemic Lupus Erythematosus epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Systemic Lupus Erythematosus patients, history of the disease at the population level (Systemic Lupus Erythematosus prevalence, Systemic Lupus Erythematosus incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nSystemic Lupus Erythematosus patient flow: Systemic Lupus Erythematosus prevalence, diagnosed, and drug-treated patients\nDemographics: Systemic Lupus Erythematosus patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Systemic Lupus Erythematosus market sizing, assessing market potential, and developing drug forecast models\nIdentify Systemic Lupus Erythematosus patients segments through age groups, gender, and disease sub-types\nEvaluate Systemic Lupus Erythematosus market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005191/en/\n'

Lupus Foundation of America Unites Nationwide Lupus Community to Make an Impact for Lupus Awareness Month this May

Retrieved on: 
Friday, April 30, 2021
Medical specialties, Autoimmune diseases, Clinical medicine, Medicine, Lupus Foundation of America, Cutaneous lupus erythematosus, Connective tissue diseases, Lupus, Sjögren syndrome, Lupus Canada

"I know from firsthand experience with my patients how important it is to increase awareness and make lupus visible.

Key Points: 
  • "I know from firsthand experience with my patients how important it is to increase awareness and make lupus visible.
  • "\nYou can make an impact this May for Lupus Awareness Month and help Make Lupus Visible.
  • With a donation of $50, receive limited edition Lupus Awareness Month sunglasses.\n"This May, the Lupus Foundation of America invites everyone, friends, family and supporters across the nation, to make a difference in the fight to end lupus," said Stevan W. Gibson, president and CEO, Lupus Foundation of America.
  • Learn more about the Lupus Foundation of America at lupus.org .\n'

Lupus Foundation of America Debuts New, Free Education Series - Lupus & You: Answers. Advocacy. Action

Retrieved on: 
Tuesday, March 23, 2021
Medical specialties, Lupus Foundation of America, Clinical medicine, Autoimmune diseases, Medicine, Lupus, Lupus Canada, The Hibbs Lupus Trust

WASHINGTON, March 23, 2021 /PRNewswire/ -- The Lupus Foundation of America is excited to launch its free, live educational series Lupus & You: Answers.

Key Points: 
  • WASHINGTON, March 23, 2021 /PRNewswire/ -- The Lupus Foundation of America is excited to launch its free, live educational series Lupus & You: Answers.
  • where people with lupus, their family members and friends can learn about the latest in lupus research and managing the disease.
  • Through a comprehensive program of research, education, and advocacy, we lead the fight to improve the quality of life for all people affected by lupus.
  • Learn more about the Lupus Foundation of America at lupus.org .

HealthWell Foundation Reopens Systemic Lupus Erythematosus (SLE) Fund

Retrieved on: 
Tuesday, December 1, 2020
Lupus Foundation of America, Medical specialties, Lupus erythematosus, Cutaneous lupus erythematosus, Clinical medicine, Lupus Canada

GERMANTOWN, Md., Dec. 1, 2020 /PRNewswire/ --The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is excited to announce that it has reopened its fund to assist individuals living with Systemic Lupus Erythematosus (SLE).

Key Points: 
  • GERMANTOWN, Md., Dec. 1, 2020 /PRNewswire/ --The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is excited to announce that it has reopened its fund to assist individuals living with Systemic Lupus Erythematosus (SLE).
  • In addition to reopening the fund, the HealthWell Foundation is honored to announce that it has entered into a partnership with the Lupus Foundation of America (LFA).
  • The Lupus Foundation of America estimates that there are approximately 1.5 million Americans affected by all forms of lupus.
  • To determine eligibility and apply for financial assistance, visit HealthWell's Systemic Lupus Erythematosus Fund page.